We are live on !
Find out more
Emerald Acquisition Portfolio holdings
AUM
$51.8B
Turnover
12.96%
This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$51.8B
AUM Growth
-$5.97B
(-10%)
Cap. Flow
-$8.46B
Cap. Flow % of AUM
Cap. Flow %
-16.35%
Top 10 Holdings %
Top 10 Hldgs %
10.38%
Holding
3,194
New
200
Increased
788
Reduced
1,868
Closed
214
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.3
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KeyCorp
KEY
|
+$59.1M |
| 2 |
IHS Markit Ltd. Common Shares
INFO
|
+$56.2M |
| 3 |
Du Pont De Nemours E I
DD
|
+$54M |
| 4 |
Alibaba
BABA
|
+$47.2M |
| 5 |
McKesson
MCK
|
+$43.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC CORPORATION
EMC
|
+$142M |
| 2 |
Johnson & Johnson
JNJ
|
+$133M |
| 3 |
Wells Fargo
WFC
|
+$131M |
| 4 |
TSMC
TSM
|
+$120M |
| 5 |
Corning
GLW
|
+$101M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.36% |
| 2 | Healthcare | 13.13% |
| 3 | Technology | 12.22% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CSII
2226
DELISTED
Cardiovascular Systems, Inc.
CSII
| $741K | ﹤0.01% |
+31,193
| New | +$683K |
2016 Q3
0 quarters
|
|
|
RESI
2227
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $739K | ﹤0.01% |
67,760
-97,675
| -59% | -$986K |
2016 Q2
1 quarter
|
|
|
DNR
2228
DELISTED
Denbury Resources, Inc.
DNR
| $738K | ﹤0.01% |
228,427
-1,439,502
| -86% | -$4.4M |
2016 Q2
1 quarter
|
|
2229
DELISTED
Heidrick & Struggles
HSII
| $737K | ﹤0.01% |
39,696
-14,660
| -27% | -$272K |
2016 Q2
1 quarter
|
|
|
APTS
2230
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $736K | ﹤0.01% |
54,502
-58,992
| -52% | -$843K |
2016 Q2
1 quarter
|
|
2231
DELISTED
Enzo Biochem, Inc.
ENZ
| $732K | ﹤0.01% |
143,988
+48,039
| +50% | +$287K |
2016 Q2
1 quarter
|
|
2232
Materion
MTRN
$4.57B
| $730K | ﹤0.01% |
+23,782
| New | +$668K |
2016 Q3
0 quarters
|
|
2233
Quantum Corp
QMCO
$669M
| $730K | ﹤0.01% |
6,197
| – | – |
2016 Q2
1 quarter
|
|
2234
CF Industries
CF
$17.9B
| $729K | ﹤0.01% |
29,930
-383,651
| -93% | -$9.36M |
2016 Q2
1 quarter
|
|
2235
United Parks & Resorts
PRKS
$1.41B
| $729K | ﹤0.01% |
54,111
-412,805
| -88% | -$5.65M |
2016 Q2
1 quarter
|
|
|
LJPC
2236
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $726K | ﹤0.01% |
+30,502
| New | +$575K |
2016 Q3
0 quarters
|
|
2237
American Public Education
APEI
$894M
| $722K | ﹤0.01% |
36,474
+1,791
| +5% | +$43.4K |
2016 Q2
1 quarter
|
|
2238
DELISTED
Liberty Broadband Class C
LBRDK
| $719K | ﹤0.01% |
10,048
-3,296
| -25% | -$220K |
2016 Q2
1 quarter
|
|
2239
Geron
GERN
$726M
| $718K | ﹤0.01% |
317,866
-144,579
| -31% | -$375K |
2016 Q2
1 quarter
|
|
2240
PRA Group
PRAA
$751M
| $717K | ﹤0.01% |
20,746
+16,771
| +422% | +$494K |
2016 Q2
1 quarter
|
|
2241
PetMed Express
PETS
$25.6M
| $714K | ﹤0.01% |
35,226
+15,111
| +75% | +$304K |
2016 Q2
1 quarter
|
|
2242
National CineMedia
NCMI
$182M
| $712K | ﹤0.01% |
4,838
+266
| +6% | +$40.6K |
2016 Q2
1 quarter
|
|
2243
Natural Gas Services Group
NGS
$387M
| $711K | ﹤0.01% |
28,900
-3,200
| -10% | -$77.8K |
2016 Q2
1 quarter
|
|
2244
NPK International
NPKI
$914M
| $711K | ﹤0.01% |
96,662
-112,192
| -54% | -$742K |
2016 Q2
1 quarter
|
|
|
BCRH
2245
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
| $709K | ﹤0.01% |
38,725
+35,256
| +1,016% | +$632K |
2016 Q2
1 quarter
|
|
|
ACOR
2246
DELISTED
Acorda Therapeutics
ACOR
| $708K | ﹤0.01% |
283
+40
| +16% | +$119K |
2016 Q2
1 quarter
|
|
|
VWTR
2247
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $708K | ﹤0.01% |
+60,018
| New | +$631K |
2016 Q3
0 quarters
|
|
2248
Ionis Pharmaceuticals
IONS
$7.3B
| $706K | ﹤0.01% |
19,268
-35,308
| -65% | -$1.1M |
2016 Q2
1 quarter
|
|
2249
Altimmune
ALT
$422M
| $705K | ﹤0.01% |
+811
| New | +$636K |
2016 Q3
0 quarters
|
|
2250
Tootsie Roll Industries
TR
$2.8B
| $704K | ﹤0.01% |
25,688
-106,451
| -81% | -$2.97M |
2016 Q2
1 quarter
|
|
Similar funds
ACN
Emerald Acquisition's Q3 2016 Portfolio in Review
As of Q3 2016, Emerald Acquisition held 3,194 positions worth $51.8B, down 10% from $57.7B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Emerald Acquisition withdrew a net $8.46B in Q3 2016, closing 214 positions and reducing 1,868 holdings. Its most notable exit was EMC CORPORATION, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Emerald Acquisition opened a new position in Novo Nordisk worth $13.9M.
- Emerald Acquisition's largest Q3 2016 buy was Novo Nordisk: 666,610 shares worth $13.9M.
- Emerald Acquisition added most to KeyCorp in Q3 2016, an estimated $59.1M increase.
- Emerald Acquisition's biggest Q3 2016 reduction was Johnson & Johnson, cutting an estimated $133M.
- Emerald Acquisition fully exited EMC CORPORATION in Q3 2016, selling an estimated $142M.
- Emerald Acquisition's ten largest holdings make up 10% of its $51.8B portfolio in Q3 2016.
- Emerald Acquisition opened 200 new positions and closed 214 in Q3 2016.
- Emerald Acquisition's portfolio value fell 10% quarter-over-quarter to $51.8B.
Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.